InvestorsHub Logo
Post# of 251813
Next 10
Followers 10
Posts 1097
Boards Moderated 0
Alias Born 08/23/2004

Re: ciotera post# 212100

Monday, 06/26/2017 3:05:59 PM

Monday, June 26, 2017 3:05:59 PM

Post# of 251813
The primary endpoint for the trial as defined by a SPA is progression free survival. OS will be less relevant as patients in the treatment arm are allowed to move on to Adcetris at progression. This is how first-line Hodgkin's lymphoma trials readout.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.